R. Isaacs

963 total citations
26 papers, 700 citations indexed

About

R. Isaacs is a scholar working on Oncology, Molecular Biology and Surgery. According to data from OpenAlex, R. Isaacs has authored 26 papers receiving a total of 700 indexed citations (citations by other indexed papers that have themselves been cited), including 13 papers in Oncology, 9 papers in Molecular Biology and 6 papers in Surgery. Recurrent topics in R. Isaacs's work include Bone health and treatments (9 papers), Metabolism, Diabetes, and Cancer (7 papers) and Protein Kinase Regulation and GTPase Signaling (5 papers). R. Isaacs is often cited by papers focused on Bone health and treatments (9 papers), Metabolism, Diabetes, and Cancer (7 papers) and Protein Kinase Regulation and GTPase Signaling (5 papers). R. Isaacs collaborates with scholars based in United States, Canada and United Kingdom. R. Isaacs's co-authors include J. F. Whitfield, Gordon E. Willick, K. Clark, Warwick Hunter, Paul Morley, Ian C. MacDonald, R. H. Fox, S. MacLean, Adam Fry and V. Ross and has published in prestigious journals such as Nucleic Acids Research, Endocrinology and Journal of Bone and Mineral Research.

In The Last Decade

R. Isaacs

25 papers receiving 668 citations

Peers

R. Isaacs
Wei Ooi Canada
Kaushik Mandal United States
Yahong Yu China
Manhui Pang United States
T Gilg Germany
Wei Ooi Canada
R. Isaacs
Citations per year, relative to R. Isaacs R. Isaacs (= 1×) peers Wei Ooi

Countries citing papers authored by R. Isaacs

Since Specialization
Citations

This map shows the geographic impact of R. Isaacs's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by R. Isaacs with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites R. Isaacs more than expected).

Fields of papers citing papers by R. Isaacs

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by R. Isaacs. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by R. Isaacs. The network helps show where R. Isaacs may publish in the future.

Co-authorship network of co-authors of R. Isaacs

This figure shows the co-authorship network connecting the top 25 collaborators of R. Isaacs. A scholar is included among the top collaborators of R. Isaacs based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with R. Isaacs. R. Isaacs is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Isaacs, R., et al.. (2024). Enhancing South Africans universities engagement during student recruitment through social media marketing. Perspectives Policy and Practice in Higher Education. 29(4). 256–266. 1 indexed citations
2.
Lebbé, Célèste, Caroline Dutriaux, Thierry Lesimple, et al.. (2016). Pimasertib (PIM) versus dacarbazine (DTIC) in patients (pts) with cutaneous NRAS melanoma: a controlled, open-label phase II trial with crossover. Annals of Oncology. 27. vi389–vi389. 13 indexed citations
3.
Zdenkowski, Nicholas, et al.. (2016). A survey of Australian and New Zealand clinical practice with neoadjuvant systemic therapy for breast cancer. Internal Medicine Journal. 46(6). 677–683. 5 indexed citations
4.
Harvey, V.J., Katrina Sharples, R. Isaacs, et al.. (2013). A randomized phase II study comparing capecitabine alone with capecitabine and oral cyclophosphamide in patients with advanced breast cancer-cyclox II. Annals of Oncology. 24(7). 1828–1834. 5 indexed citations
5.
Vaughan, Neil, Venketesh N. Dubey, Minnesota Wee, & R. Isaacs. (2012). Epidural needle length measurement by video processing. TeesRep (Teesside University). A8–A8. 1 indexed citations
6.
Blanke, Charles D., Jeffrey Shultz, James D. Cox, et al.. (2002). A double-blind placebo-controlled randomized phase III trial of 5-fluorouracil and leucovorin, plus or minus trimetrexate, in previously untreated patients with advanced colorectal cancer. Annals of Oncology. 13(1). 87–91. 24 indexed citations
7.
Isaacs, R., Warwick Hunter, & K. Clark. (2001). Tamoxifen as Systemic Treatment of Advanced Breast Cancer during Pregnancy—Case Report and Literature Review. Gynecologic Oncology. 80(3). 405–408. 84 indexed citations
8.
Whitfield, J. F., R. Isaacs, Balu Chakravarthy, et al.. (2001). Stimulation of Protein Kinase C Activity in Cells Expressing Human Parathyroid Hormone Receptors by C- and N-Terminally Truncated Fragments of Parathyroid Hormone 1–34. Journal of Bone and Mineral Research. 16(3). 441–447. 23 indexed citations
9.
Morley, Paul, J. F. Whitfield, Gordon E. Willick, et al.. (2001). The effect of monocyclic and bicyclic analogs of human parathyroid hormone (hPTH)-(1-31)NH2 on bone formation and mechanical strength in ovariectomized rats. Calcified Tissue International. 68(2). 95–101. 13 indexed citations
10.
Sung, Wing L., Bernard Chan, R. Isaacs, et al.. (2000). High‐Yield Expression of Fully Bioactive N‐Terminal Parathyroid Hormone Analog in Escherichia coli. IUBMB Life. 49(2). 131–135. 4 indexed citations
11.
Whitfield, J. F., Paul Morley, Gordon E. Willick, et al.. (1999). Stimulation of Femoral Trabecular Bone Growth in Ovariectomized Rats by Human Parathyroid Hormone (hPTH)-(1-30)NH 2. Calcified Tissue International. 65(2). 143–147. 12 indexed citations
12.
Whitfield, J. F., Paul Morley, Gordon E. Willick, et al.. (1998). Comparison of the Abilities of Human Parathyroid Hormone (hPTH)-(1-34) and [Leu27]-cyclo(Glu22-Lys26)-hPTH-(1-31)NH2 to Stimulate Femoral Trabecular Bone Growth in Ovariectomized Rats. Calcified Tissue International. 63(5). 423–428. 7 indexed citations
13.
Whitfield, J. F., Paul Morley, V. Ross, et al.. (1997). The Hypotensive Actions of Osteogenic and Nonosteogenic Parathyroid Hormone Fragments. Calcified Tissue International. 60(3). 302–308. 10 indexed citations
14.
Whitfield, J. F., Paul Morley, Gordon E. Willick, et al.. (1997). Comparison of the ability of recombinant human parathyroid hormone, rhPTH-(1–84), and hPTH-(1–31)NH2 to stimulate femoral trabecular bone growth in ovariectomized rats. Calcified Tissue International. 60(1). 26–29. 20 indexed citations
15.
Whitfield, J. F., Paul Morley, Gordon E. Willick, et al.. (1997). Comparison of the Abilities of Human Parathyroid Hormone(1-31)NH2 and Human Parathyroid Hormone-Related Protein(1-31)NH2 to Stimulate Femoral Trabecular Bone Growth in Ovariectomized Rats. Calcified Tissue International. 61(4). 322–326. 9 indexed citations
16.
Whitfield, J. F., et al.. (1996). Stimulation of the growth of femoral trabecular bone in ovariectomized rats by the novel parathyroid hormone fragment, hPTH-(1–31)NH2 (Ostabolin). Calcified Tissue International. 58(2). 81–87. 51 indexed citations
17.
Isaacs, R., Weg M. Ongkeko, Adrian L. Harris, et al.. (1996). p53 Regulates the Minimal Promoter of the Human Topoisomerase II  Gene. Nucleic Acids Research. 24(22). 4464–4470. 78 indexed citations
18.
Whitfield, J. F., Paul Morley, V. Ross, R. Isaacs, & R. H. Rixon. (1995). Restoration of severely depleted femoral trabecular bone in ovariectomized rats by parathyroid hormone-(1?34). Calcified Tissue International. 56(3). 227–231. 31 indexed citations
19.
Isaacs, R., et al.. (1993). Role of computed tomography in the staging of primary breast cancer. British journal of surgery. 80(9). 1137–1137. 15 indexed citations
20.
Jouishomme, Hervé, J. F. Whitfield, Balu Chakravarthy, et al.. (1992). The protein kinase-C activation domain of the parathyroid hormone.. Endocrinology. 130(1). 53–60. 132 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026